Growth Metrics

Neogenomics (NEO) Convertible Debt (2020 - 2026)

Neogenomics filings provide 7 years of Convertible Debt readings, the most recent being $342.2 million for Q1 2026.

  • On a quarterly basis, Convertible Debt changed 0.45% to $342.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $342.2 million, a 0.45% change, with the full-year FY2025 number at $341.9 million, changed 0.45% from a year prior.
  • Convertible Debt hit $342.2 million in Q1 2026 for Neogenomics, roughly flat from $341.9 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $538.9 million in Q1 2024 to a low of $339.6 million in Q2 2024.
  • Median Convertible Debt over the past 5 years was $533.2 million (2022), compared with a mean of $444.2 million.
  • Biggest five-year swings in Convertible Debt: grew 0.54% in 2024 and later crashed 36.78% in 2025.
  • Neogenomics' Convertible Debt stood at $535.3 million in 2022, then rose by 0.54% to $538.2 million in 2023, then crashed by 36.76% to $340.3 million in 2024, then rose by 0.45% to $341.9 million in 2025, then grew by 0.11% to $342.2 million in 2026.
  • The last three reported values for Convertible Debt were $342.2 million (Q1 2026), $341.9 million (Q4 2025), and $341.5 million (Q3 2025) per Business Quant data.